Nigel:
Beginning on Monday 25 February and for the next few days thereafter (if I am reading the chart correctly), LEON popped up to $12, although it has sagged a bit since then. I can't find any news that accounts for the sudden rise. Do you have any idea what might have caused it, and/or the subsequent sag? I need to look at their website to see if it says when they will be releasing their fourth quarter and fiscal year results.
Could LEON's fourth quarter acquisition of Netgenics (and subsequent layoff, I hope of redundant personnel), together with their third quarter partnerships or collaborations with IBM, Paradigm Genetics, and Ace Biosciences, and together also with their new Web Based Training (with Bayer and Nestle as customers) and Hosted Bioinformatics (with UCB Research --- albeit a new name to me --- as a customer), generate a fourth quarter sharp jump in revenue, and reduction in losses? If so, together with their fourth quarter sale of Tripos for $22.5 million total ($890k accrued Tripos dividend + $21.6 sale) and resulting balance sheet improvement (I assume), might a dramatic press release generate more favorable interest in the stock?
I've got a miniscule position (77 shares, resulting from LEON's purchase of my Trega holding in which I had a disastrous loss), but am wondering if I should expand my LEON position. Before 25 February would have been a better time to act, of course.
On the other hand, maybe the 6 Feb 2002 LEON press release is written "well" to portray events as major advances that really are minor accomplishments, at least minor relative to costs?
Any thoughts?
Cordially, Roger Folsom |
